Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Pregabalin for the treatment of postoperative pain: Results from three controlled trials using different surgical models

Singla, NK and Echelly, J and Lionberger, DR and Gimbel, J and Sanin, L and Sporn, J and Yang, R and Cheung, R and Knapp, L and Parsons, B (2014) Pregabalin for the treatment of postoperative pain: Results from three controlled trials using different surgical models. Journal of Pain Research, 8. 9 - 20. ISSN 1178-7090

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (554kB)
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

© 2015 Singla et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. Conclusion: There were no significant differences between pregabalin and placebo with respect to the primary pain intensity measure in each of the three clinical trials. These studies encompass a large dataset (1,233 patients in total), and their results should be considered when assessing pregabalin’s effectiveness in postoperative pain. Further studies are required to determine the potential pain-reducing benefit of pregabalin in the postoperative setting.Patients and methods: This study reports findings from three separate, multicenter, randomized, double-blind, placebo-controlled trials of adjunctive pregabalin for the treatment of postoperative pain. Patients underwent one of three categories of surgical procedures (one procedure per study): elective inguinal hernia repair (post-IHR); elective total knee arthroplasty (post-TKA); or total abdominal hysterectomy (posthysterectomy). The primary endpoint in each trial, mean worst pain over the past 24 hours, was assessed 24 hours post-IHR and posthysterectomy, and 48 hours post-TKA. Patients rated their pain on a scale from 0 to 10, with higher scores indicating greater pain severity.Purpose: To evaluate the efficacy and safety of pregabalin (150 or 300 mg/d) as an adjunctive therapy for the treatment of postoperative pain.Results: In total, 425 (post-IHR), 307 (post-TKA), and 501 (posthysterectomy) patients were randomized to treatment. There were no statistically significant differences between the pregabalin and placebo groups with respect to the primary endpoint in any of the three trials. The least squares mean difference in worst pain, between 300 mg/d pregabalin and placebo, was-0.7 (95% confidence interval [CI] =-1.4,-0.1; Hochberg adjusted P=0.067) post-IHR;-0.34 (95% CI =-1.07, 0.39; P=0.362) post-TKA; and-0.2 (95% CI =-0.66, 0.31; P=0.471) posthysterectomy.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Singla, NK
Echelly, J
Lionberger, DR
Gimbel, J
Sanin, L
Sporn, J
Yang, R
Cheung, R
Knapp, L
Parsons, B
Date: 23 December 2014
Date Type: Publication
Journal or Publication Title: Journal of Pain Research
Volume: 8
Page Range: 9 - 20
DOI or Unique Handle: 10.2147/jpr.s67841
Schools and Programs: School of Medicine > Anesthesiology
Refereed: Yes
ISSN: 1178-7090
Date Deposited: 22 May 2015 21:56
Last Modified: 29 Jan 2019 15:55
URI: http://d-scholarship.pitt.edu/id/eprint/24688

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item